Malignant neoplasm of medulla of left adrenal gland
ICD-10 C74.12 is a billable code used to indicate a diagnosis of malignant neoplasm of medulla of left adrenal gland.
C74.12 refers to a malignant tumor located in the medulla of the left adrenal gland, which is responsible for producing catecholamines such as epinephrine and norepinephrine. These hormones play critical roles in the body's stress response, regulating heart rate, blood pressure, and metabolism. Malignant neoplasms of the adrenal medulla can lead to excessive hormone production, resulting in symptoms such as hypertension, palpitations, and anxiety. Diagnosis typically involves imaging studies like CT or MRI, along with biochemical tests to assess hormone levels. Treatment often includes surgical resection of the tumor, and in some cases, chemotherapy or radiation therapy may be indicated. The prognosis depends on the tumor's size, stage, and the presence of metastasis. Accurate coding is essential for proper treatment planning and reimbursement.
Detailed pathology reports, imaging studies, and treatment plans.
Management of adrenal tumors, including surgical interventions and follow-up care.
Ensure accurate staging and grading of tumors for treatment planning.
Hormonal assay results, patient symptomatology, and treatment response.
Evaluation of hormone-secreting tumors and management of associated metabolic disorders.
Documenting the impact of hormone levels on patient health and treatment outcomes.
Used for surgical removal of malignant adrenal tumors.
Operative reports detailing the procedure and findings.
Oncology and surgery must coordinate on documentation.
Common symptoms include hypertension, palpitations, anxiety, and excessive sweating due to catecholamine overproduction.
